Global Ibuprofen Market By Type (Rx, OTC), By Form (Tablets, Capsules, Suspension), By Indication (Inflammatory Disease, Rheumatoid Arthritis, Pain/Fever/Dysmenorrhea), By Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Report Overview

The Global Ibuprofen Market size is expected to be worth around USD 114.09 Million by 2032 from USD 90 million in 2022, growing at a CAGR of 2.4% during the forecast period 2023 to 2032.

Ibuprofen is mostly used in the treatment of chronic diseases such as cancer, cardiovascular diseases, arthritis, etc., and this element is expected to foster increased revenue growth prospects for this global market over the forecast period.

Market.US announces the publication of its most recently generated research report titled, “Global Ibuprofen Market by Type (Rx (Medical Prescription), OTC (Over-The-Counter)), Form (Tablets, Capsules, Suspension), Indication(Inflammatory Disease, Rheumatoid Arthritis, Pain/Fever/Dysmenorrhea, Other Indications), Distribution Channel(Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies), and by Region – Global Forecast to 2031”, which offers a holistic view of the Global Ibuprofen Market through systematic segmentation that covers every aspect of the target market.

Market Dynamics:

The global intravenous (IVI) ibuprofen industry is experiencing a significant increase in the incidence of cardiovascular diseases and arthritis. Many cancers, including osteosarcoma, nerve cancer, leukemia, and bone cancer, cause mild to very severe pain. According to the American Cancer Society of (ACS), approximately 3,910 cases of bone cancers were discovered in the U.S. in 2021. The high bioavailability and quick analgesic actions of ibuprofen will likely fuel their adoption in the future.

The market is also growing due to an increase in bone and muscle disorders such as ankylosing, a rare form of arthritis, and rheumatoid. According to the Journal of Rheumatology’s report titled “Prevalence of ankylosing Spondylitis In Spain”, 7.3% of Spanish citizens had a positive screening for this condition in 2022. The number of diagnostic and orthopedic centers has increased, allowing for better diagnosis and treatment. According to Definitive Healthcare Organization in the United States, there were over 30,000. The IV ibuprofen industry is growing because of an increase in orthopedic surgery and an increased need for intravenous pain medication.

The intravenous (IVI) ibuprofen industry is also growing due to an increase in the number of musculoskeletal conditions. World Health Organization (WHO) estimates that approximately 1.71 billion people suffer from musculoskeletal disorders in the world. The market’s growth is also due to the availability of ibuprofen over the counter.

The intravenous (IV), ibuprofen market is growing due to an increase in product approvals and government regulations. The US Food and Drug Administration (FDA) published the December 2020 list of NSAIDs that are available over-the-counter and prescription. It includes ibuprofen (naproxen), diclofenac and celecoxib. Ibuprofen as well as naproxen and naproxen can also be purchased OTC at lower strengths.

The U.S. Food and Drug Administration (FDA) has approved intravenous (IV), ibuprofen injections to be administered to children at specific doses. In order to meet the growing demand for IV ibuprofen shots, intravenous (IV), ibuprofen injections have been approved by the U.S. food and drug administration (FDA). The market is growing because of an increase in children. According to the State of America’s Children 2021 report, almost 22% of the U.S. population were children.

The market’s growth is expected to be aided by the development of intravenous ibuprofen formulas. Cumberland Pharmaceuticals (a global leader in the development, manufacture, and marketing of a wide range of innovative pharmaceutical products) announced in November 2021 that it had received approval from the U.S. Food and Drug Administration for its color. This intravenous ibuprofen was used for pre-operative administration. Side effects of ibuprofen can hinder the market’s growth.

Ibuprofen Market Scope:

Ibuprofen is a Nonsteroidal Anti-Inflammatory Drug (NSAID), and it belongs to a group category of propionic acid derivatives. The drug was first introduced in 1961, and was initially marketed as “Brufen”. Currently, it is sold under several trade names such as Advil, Motrin, and Nuprin. It has also been licensed for Over-The-Counter (OTC) distribution and usage.

It is commonly used to treat fever, pain, and inflammation. Ibuprofen is available in the form of capsules, tablets, or powder. It is often prescribed for rheumatic musculoskeletal disorders and is also taken without the need for a prescription to treat minor aches and pains. Ibuprofen is a first-choice drug in its class as it has a low incidence rate of adverse effects. It is rapidly metabolized, usually leaving the body within 24 hours via urination.

It is used for its analgesic and anti-inflammatory effects in the treatment of diseases such as rheumatoid arthritis (including juvenile rheumatoid arthritis or Still’s disease), ankylosing spondylitis, osteoarthritis, and other non-rheumatoid (seronegative) arthropathies.

Ibuprofen is not only used in the treatment of articular rheumatic conditions, but also for specific conditions such as frozen shoulder (capsulitis), tendonitis, bursitis, tenosynovitis, lower back pain, as well as for soft-tissue injuries like strains and sprains. Apart from these, it has analgesic effects in the relief of mild to moderate pains, such as dysmenorrhea, dental, and post-operative pain.

According to the World Health Organization (WHO), 60 percent of fatalities are caused by major chronic diseases, and the Global Burden of Disease Study puts that number at 43 percent (GBD). These estimates are expected to rise as the prevalence of these diseases rises as a result of changing lifestyles. Because ibuprofen is commonly used to treat chronic conditions including cancer, cardiovascular disease, arthritis, and others, this factor is likely to boost revenue growth possibilities for this global market throughout the forecast period.

Ibuprofen can cause nausea, dyspepsia, constipation, headaches, diarrhea, rashes, dizziness, and salt and fluid retention, according to clinical investigations undertaken by many governmental and non-governmental agencies. Kidney impairment worsened asthma, elevated potassium levels in the blood, heart failure, and other severe effects have also been documented. Such consequences are projected to stifle the global market’s revenue growth.

Ibuprofen has been certified by the Food and Drug Administration (FDA) as a safe therapeutic option for children and infants under the age of six months. It’s also used in the short-term treatment of illnesses in youngsters, such as fever, toothaches, gastrointestinal pain, and so on. It’s also been utilized to shut the Patent Ductus Arteriosus (PDA), a persistent opening between the two major blood arteries originating from the heart that develops frequently in premature babies. Ibuprofen is projected to profit from a variety of lucrative revenue development opportunities in the near future as a result of its favorable benefits.

In recent years, the availability of OTC medications such as Ibuprofen on e-commerce portals has rapidly increased. The emergence of e-commerce pharmacy portals like dokteronline.com, drugs.com, cvs.com, vidal.ru, consultaremedios.com.br, mCHEMIST.com, Medidart.com, and others, as well as the availability of prescription and non-prescription drugs on these websites, are all trends that are likely to continue to provide a significant revenue boost to this global industry.

The global Ibuprofen market is segmented on the basis of type, form, indication, distribution channel, and region. Based on type market segmentation, the OTC sub-segment is expected to account for a majority revenue share of this target market. On the basis of form, the tablet sub-segment is expected to generate a majority of revenue share over the forecast period. With respect to the indication market segmentation, the pain/fever/dysmenorrhea sub-segment accounted for the majority of the market share.

With regards to distribution channels, retailer pharmacies accounted for the maximum number of revenue shares, followed by online pharmacies. On the basis of region, the markets in the North American region are projected to account for the majority share in terms of revenue of the global Ibuprofen market, and these markets are projected to maintain their respective market positions over the forecast period.

The research report on the global ibuprofen market includes profiles of some of the major companies such as– Novartis AG, Pfizer Inc., Abbott Laboratories, Gilead Sciences, Inc., Merck KGaA, Astellas Pharma Inc., Glenmark Pharmaceuticals Ltd., NATCO Pharma Ltd., Basilea Pharmaceutical AG, and Leadiant Biosciences Inc. among others.

Global Ibuprofen Market Segmentation Based on Type, Form, Indication, Distribution Channel, and Region

Based on Type

• Rx (Medical Prescription)
• OTC (Over-The-Counter)

Based on Form

• Tablets
• Capsules
• Suspension

Based on Indication

• Inflammatory Disease
• Rheumatoid Arthritis
• Pain/Fever/Dysmenorrhea
• Other Indications

Based on Distribution Channel

• Hospital Pharmacies
• Retailer Pharmacies
• Online Pharmacies

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Based on Key Players:

• Novartis AG
• Pfizer Inc.
• Abbott Laboratories
• Gilead Sciences Inc.
• Merck KGaA
• Astellas Pharma Inc.
• Glenmark Pharmaceuticals Ltd.
• NATCO Pharma Ltd.
• Basilea Pharmaceutical AG
• Leadiant Biosciences Inc.
• others

For the Ibuprofen Market research study, the following years have been considered to estimate the market size: